Company research
HUTCHMED (China) Ltd
CIK 1648257Updated Sep 26, 2026
SecuritiesHMDCF · OTC · equityHCM · NASDAQ · adr
Name history
Hutchison China MediTech Ltd · through Apr 29, 2021
HMDCF price & chart
Loading TradingView…
OTC:HMDCF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,753,097,000Source | 1,274,196,000Source | 1,279,773,000Source | 1,029,445,000Source |
| Property, Plant and Equipment, NetUSD | 94,623,000Source | 92,498,000Source | 99,727,000Source | 75,947,000Source |
| GoodwillUSD | 3,112,000Source | 2,990,000Source | 3,064,000Source | 3,137,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 8,941,000Source | — | 21,000Source | 85,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 71,330,000Source | 153,958,000Source | 283,589,000Source | 313,278,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 126,750,000Source | 155,537,000Source | 116,894,000Source | 97,988,000Source |
| Inventory, NetUSD | 41,129,000Source | 50,400,000Source | 50,258,000Source | 56,690,000Source |
| Assets, CurrentUSD | 1,567,342,000Source | 1,066,555,000Source | 1,096,839,000Source | 839,888,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,027,000Source | 4,497,000Source | 4,665,000Source | 8,722,000Source |
| Other Assets, NoncurrentUSD | 20,092,000Source | 15,433,000Source | 14,675,000Source | 15,745,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 501,835,000Source | 502,343,000Source | 536,386,000Source | 392,575,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 87,233,000Source | 87,160,000Source | 87,126,000Source | 86,478,000Source |
| Retained Earnings (Accumulated Deficit)USD | -378,643,000Source | -833,172,000Source | -870,869,000Source | -971,481,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -4,532,000Source | -11,585,000Source | -8,163,000Source | -1,903,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,237,926,000Source | 759,929,000Source | 730,541,000Source | 610,367,000Source |
| Additional Paid in Capital, Common StockUSD | 1,533,868,000Source | 1,517,526,000Source | 1,522,447,000Source | 1,497,273,000Source |
| Liabilities and EquityUSD | 1,753,097,000Source | 1,274,196,000Source | 1,279,773,000Source | 1,029,445,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 315,775,000Source | 376,562,000Source | 403,027,000Source | 353,903,000Source |
| Operating Lease, Liability, CurrentUSD | 2,881,000Source | 2,925,000Source | 3,927,000Source | 3,708,000Source |
| Accounts Payable, CurrentUSD | 45,533,000Source | 42,521,000Source | 36,327,000Source | 71,115,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,852,000Source | 4,089,000Source | 2,860,000Source | 5,196,000Source |
| Deferred Income Tax Liabilities, NetUSD | 255,000Source | 2,990,000Source | 1,484,000Source | 2,710,000Source |
| Other Liabilities, NoncurrentUSD | — | 10,836,000Source | 11,346,000Source | 12,662,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 13,336,000Source | 11,924,000Source | 12,846,000Source | 26,503,000Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 1,367,275,000Source | 836,110,000Source | 886,336,000Source | 630,996,000Source |
| Deferred Revenue, NoncurrentUSD | — | 48,432,000Source | 69,480,000Source | — |
| Long-term Debt, Current MaturitiesUSD | 24,971,000Source | 23,372,000Source | 31,155,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 68,189,000Source | 59,434,000Source | 48,189,000Source | 18,104,000Source |
| Short-term InvestmentsUSD | 1,295,945,000Source | 682,152,000Source | 602,747,000Source | 317,718,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 457,732,000Source | 38,170,000Source | 101,094,000Source | -360,386,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 13,308,000Source | 12,341,000Source | 8,207,000Source | 8,664,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -28,862,000Source | 38,545,000Source | 21,336,000Source | 14,451,000Source |
| Increase (Decrease) in InventoriesUSD | -9,542,000Source | 772,000Source | -4,135,000Source | 21,213,000Source |
| Increase (Decrease) in Accounts PayableUSD | 3,012,000Source | 6,194,000Source | -32,542,000Source | 29,938,000Source |
| Deferred Income Tax Expense (Benefit)USD | -118,000Source | 5,308,000Source | 2,226,000Source | -3,563,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -64,657,000Source | 497,000Source | 219,258,000Source | -268,599,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -29,410,000Source | -96,060,000Source | -291,136,000Source | 296,588,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 14,148,000Source | 17,933,000Source | 32,612,000Source | 36,664,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | 36,064,000Source | 9,071,000Source | 48,084,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 7,836,000Source | -30,667,000Source | 48,660,000Source | -82,763,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -82,628,000Source | -129,631,000Source | -29,689,000Source | -64,264,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 71,330,000Source | 153,958,000Source | 283,589,000Source | 313,278,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 2,518,000Source | 2,509,000Source | 421,000Source | 150,000Source |
| Income Taxes Paid, NetUSD | 62,411,000Source | 3,587,000Source | 3,728,000Source | 18,891,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | — | — | — | 18,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 1,367,275,000Source | 836,110,000Source | 886,336,000Source | 630,996,000Source |
| DepreciationUSD | 11,998,000Source | 12,070,000Source | 7,888,000Source | 8,327,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | 130,000Source |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | 476,896,000Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 21,000Source | -10,000Source | -86,000Source | -111,000Source |
| General and Administrative ExpenseUSD | 66,722,000Source | 64,296,000Source | 79,784,000Source | 92,173,000Source |
| GoodwillUSD | 3,112,000Source | 2,990,000Source | 3,064,000Source | 3,137,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 22,651,000Source | 46,469,000Source | 47,295,000Source | 49,753,000Source |
| Income Tax Expense (Benefit)USD | 63,610,000Source | 7,192,000Source | 4,509,000Source | -283,000Source |
| InterestExpenseNonoperatingUSD | 2,865,000Source | 2,872,000Source | — | — |
| Investment Income, InterestUSD | 49,877,000Source | 40,080,000Source | 36,145,000Source | 9,599,000Source |
| Net Income (Loss) Attributable to ParentUSD | 456,909,000Source | 37,729,000Source | 100,780,000Source | -360,835,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 823,000Source | 441,000Source | 314,000Source | 449,000Source |
| Nonoperating Income (Expense)USD | 60,955,000Source | 42,598,000Source | 39,933,000Source | -2,729,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 5,372,000Source |
| Operating Lease, Impairment LossUSD | — | 1,889,000Source | 2,088,000Source | — |
| Proceeds from Issuance of Common StockUSD | 1,578,000Source | 790,000Source | 5,094,000Source | 174,000Source |
| Stock or Unit Option Plan ExpenseUSD | 2,513,000Source | 3,069,000Source | 6,184,000Source | 6,736,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 548,512,000Source | 630,201,000Source | 837,999,000Source | 426,409,000Source |
| Cost of RevenueUSD | 336,349,000Source | 348,884,000Source | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | -39,160,000Source | -43,705,000Source | 18,375,000Source | -407,693,000Source |
| Income Tax Expense (Benefit)USD | 63,610,000Source | 7,192,000Source | 4,509,000Source | -283,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 823,000Source | 441,000Source | 314,000Source | 449,000Source |
| Net Income (Loss) Attributable to ParentUSD | 456,909,000Source | 37,729,000Source | 100,780,000Source | -360,835,000Source |
| Earnings Per Share, BasicUSD per share | 0.53Source | 0.04Source | 0.12Source | -0.43Source |
| Earnings Per Share, DilutedUSD per share | 0.52Source | 0.04Source | 0.12Source | -0.43Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 858,276,608Source | 855,351,683Source | 849,654,296Source | 847,143,540Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 872,891,120Source | 872,829,129Source | 869,196,348Source | 847,143,540Source |
| Interest Expense (non-operating)USD | 2,865,000Source | 2,872,000Source | — | — |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 587,672,000Source | 673,906,000Source | 819,624,000Source | 834,102,000Source |
| Current Income Tax Expense (Benefit)USD | 63,728,000Source | 1,884,000Source | 2,283,000Source | 3,280,000Source |
| General and Administrative ExpenseUSD | 66,722,000Source | 64,296,000Source | 79,784,000Source | 92,173,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 22,651,000Source | 46,469,000Source | 47,295,000Source | 49,753,000Source |
| Interest ExpenseUSD | — | — | 759,000Source | 652,000Source |
| Investment Income, InterestUSD | 49,877,000Source | 40,080,000Source | 36,145,000Source | 9,599,000Source |
| Labor and Related ExpenseUSD | 58,317,000Source | 69,079,000Source | 93,030,000Source | 119,306,000Source |
| Nonoperating Income (Expense)USD | 60,955,000Source | 42,598,000Source | 39,933,000Source | -2,729,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 5,372,000Source |
| Research and Development ExpenseUSD | 148,295,000Source | 212,109,000Source | 302,001,000Source | 386,893,000Source |
| Selling ExpenseUSD | 36,306,000Source | 48,617,000Source | 53,392,000Source | 43,933,000Source |